Attached files

file filename
8-K - 8-K - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20140430x8k.htm
EX-99.2 - EX-99.2 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20140430ex992e0793c.htm
EX-99.3 - EX-99.3 - PACIFIC BIOSCIENCES OF CALIFORNIA, INC.pacb-20140430ex9930cb45c.htm

Exhibit 99.1

PACIFIC BIOSCIENCES OF CALIFORNIA, INC.

Condensed Consolidated Balance Sheets

(Unaudited)

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

 

March 31,

 

December 31,

(in thousands except par value amounts)

2014

 

2013

Assets

 

 

 

 

 

Current assets

 

 

 

 

 

Cash and cash equivalents

$

41,261 

 

$

26,362 

Investments

 

77,475 

 

 

86,166 

Accounts receivable

 

3,383 

 

 

2,746 

Inventory, net

 

8,301 

 

 

10,050 

Prepaid expenses and other current assets

 

1,642 

 

 

1,135 

Total current assets

 

132,062 

 

 

126,459 

Property and equipment, net

 

8,492 

 

 

9,236 

Other long-term assets

 

486 

 

 

490 

Total assets

$

141,040 

 

$

136,185 

 

 

 

 

 

 

Liabilities and Stockholders’ Equity

 

 

 

 

 

Current liabilities

 

 

 

 

 

Accounts payable

$

3,926 

 

$

1,717 

Accrued expenses and other current liabilities

 

7,678 

 

 

9,797 

Deferred service revenue, current

 

3,904 

 

 

4,046 

Deferred contractual revenue, current

 

6,785 

 

 

6,785 

Facility financing obligation, current

 

220 

 

 

210 

Total current liabilities

 

22,513 

 

 

22,555 

Deferred service revenue, non-current

 

918 

 

 

518 

Deferred contractual revenue, non-current

 

24,823 

 

 

26,519 

Facility financing obligation, non-current

 

2,345 

 

 

2,403 

Deferred rent and other long-term liabilities

 

842 

 

 

1,114 

Notes payable

 

13,525 

 

 

13,347 

Financing derivative

 

549 

 

 

549 

Total liabilities

 

65,515 

 

 

67,005 

 

 

 

 

 

 

Commitments and contingencies

 

 

 

 

 

 

 

 

 

 

 

Stockholders’ equity

 

 

 

 

 

Preferred Stock, $0.001 par value:

 

 

 

 

 

Authorized 50,000 shares; No shares issued or outstanding

 

 —

 

 

 —

Common Stock, $0.001 par value:

 

 

 

 

 

Authorized 1,000,000 shares; Issued and outstanding 70,472 shares at March 31, 2014 and 66,275 shares at December 31, 2013, respectively

 

70 

 

 

66 

Additional paid-in capital

 

709,636 

 

 

684,413 

Accumulated other comprehensive income

 

18 

 

 

14 

Accumulated deficit

 

(634,199)

 

 

(615,313)

Total stockholders’ equity

 

75,525 

 

 

69,180 

Total liabilities and stockholders’ equity

$

141,040 

 

$

136,185